Information Collection

Subpart B - Applications

IC 5662 under ICR 202402-0910-003 · OMB 0910-0001.

⚠️ Notice: This information collection may be referencing outdated material. More recent filings for OMB 0910-0001 can be found here:

2025-12-31 - No material or nonsubstantive change to a currently approved collection
2025-07-31 - No material or nonsubstantive change to a currently approved collection

Documents and Forms

Documents and forms in this information collection
Document Name	Document Type
Form FDA 3331a Subpart B - Applications	Form and Instruction
2252 instructions rev 2021.pdf	Instruction
2252 instructions rev 2021.pdf	Instruction
FDA-2253-Instructions rev 2021.pdf	Instruction
FDA-2253-Instructions rev 2021.pdf	Instruction
PDUFA Committment Goals.pdf	Other-Performance Goals
PDUFA Committment Goals.pdf	Other-Performance Goals
FDARA 2017.pdf	Other-Legislative Authority
FDARA 2017.pdf	Other-Legislative Authority
21 USC 355 New Drugs.pdf	Other-Statutory Authority
21 USC 355 New Drugs.pdf	Other-Statutory Authority
FDA-form-356h_R13_instructional-supplement_508_FINAL_CDERProposedEdits.pdf	Instruction
FDA-form-356h_R13_instructional-supplement_508_FINAL_CDERProposedEdits.pdf	Instruction
Form FDA 3542a instructions_07-18-2023.pdf	Instruction
Form FDA 3542a instructions_07-18-2023.pdf	Instruction
0001 Form FDA 3542_instructions_07-17-2023.pdf	Instruction
0001 Form FDA 3542_instructions_07-17-2023.pdf	Instruction
FDA 3331a NDA - Field Alert Report Form FDA 3331a DRAFT FEB 2020.pdf www.fda.gov/drugs/surveillance/field-alert-reports	Form and Instruction
FDA 3331a NDA - Field Alert Report Form FDA 3331a DRAFT FEB 2020.pdf www.fda.gov/drugs/surveillance/field-alert-reports	Form and Instruction
FDA 2252 Transmittal of annual drug and biologic report under 314 FDA 2252 reports rev 2021.pdf	Form
FDA 2252 Transmittal of annual drug and biologic report under 314 FDA 2252 reports rev 2021.pdf	Form
FDA 2253 TRANSMITTAL OF ADVERTISEMENTS AND PROMOTIONAL LABELING F Form FDA 2253 propchanges 9-9-2021.pdf	Form
FDA 2253 TRANSMITTAL OF ADVERTISEMENTS AND PROMOTIONAL LABELING F Form FDA 2253 propchanges 9-9-2021.pdf	Form
FDA 356h Application to Market a New Drug, Abbreviated New Drug, Form FDA 356h with comments noting changes Aug 2022.pdf	Form
FDA 356h Application to Market a New Drug, Abbreviated New Drug, Form FDA 356h with comments noting changes Aug 2022.pdf	Form
FDA 3542a Patent Information Submitted with an NDA, or Supplement 0001 Form FDA 3542a_Dyn_Sec_Ext_07-17-2023.pdf	Form
FDA 3542a Patent Information Submitted with an NDA, or Supplement 0001 Form FDA 3542a_Dyn_Sec_Ext_07-17-2023.pdf	Form
FDA 3542 Patent Information Submitted Upon and After Approval of 0001 Form FDA 3542_Dyn_Sec_Ext_07-17-2023.pdf	Form
FDA 3542 Patent Information Submitted Upon and After Approval of 0001 Form FDA 3542_Dyn_Sec_Ext_07-17-2023.pdf	Form

Information Collection (IC) Details

View Information Collection (IC)

IC Title:

Subpart B - Applications

Agency IC Tracking Number:

Is this a Common Form? No

IC Status: Modified

Obligation to Respond: Mandatory

CFR Citation: 21 CFR 314.50-314.90 21 CFR 310.306

Information Collection Instruments:

table that charts list of instruments
Document Type	Form No.	Form Name	Instrument File	URL	Available Electronically?	Can Be Submitted Electronically?	Electronic Capability
Form and Instruction	FDA 3331a	NDA - Field Alert Report	Form FDA 3331a DRAFT FEB 2020.pdf	https://www.fda.gov/drugs/surveillance/field-alert-reports	Yes	Yes	Fillable Fileable
Form	FDA 2252	Transmittal of annual drug and biologic report under 314.81	FDA 2252 reports rev 2021.pdf		Yes	Yes	Fillable Fileable
Instruction			2252 instructions rev 2021.pdf		Yes	Yes	Fillable Fileable
Form	FDA 2253	TRANSMITTAL OF ADVERTISEMENTS AND PROMOTIONAL LABELING FOR DRUGS AND BIOLOGICS FOR HUMAN USE	Form FDA 2253 propchanges 9-9-2021.pdf		Yes	Yes	Fillable Fileable
Instruction			FDA-2253-Instructions rev 2021.pdf		Yes	Yes	Fillable Fileable
Other-Performance Goals			PDUFA Committment Goals.pdf		Yes	Yes	Paper Only
Other-Legislative Authority			FDARA 2017.pdf		Yes	Yes	Paper Only
Other-Statutory Authority			21 USC 355 New Drugs.pdf		Yes	Yes	Fillable Fileable
Form	FDA 356h	Application to Market a New Drug, Abbreviated New Drug, or Biologic, for Human Use	Form FDA 356h with comments noting changes Aug 2022.pdf		Yes	Yes	Fillable Fileable
Instruction			FDA-form-356h_R13_instructional-supplement_508_FINAL_CDERProposedEdits.pdf		Yes	Yes	Fillable Fileable
Form	FDA 3542a	Patent Information Submitted with an NDA, or Supplement	0001 Form FDA 3542a_Dyn_Sec_Ext_07-17-2023.pdf		Yes	Yes	Fillable Fileable
Instruction			Form FDA 3542a instructions_07-18-2023.pdf		Yes	Yes	Fillable Fileable
Form	FDA 3542	Patent Information Submitted Upon and After Approval of an NDA or Supplement	0001 Form FDA 3542_Dyn_Sec_Ext_07-17-2023.pdf		Yes	Yes	Fillable Fileable
Instruction			0001 Form FDA 3542_instructions_07-17-2023.pdf		Yes	Yes	Fillable Fileable

Federal Enterprise Architecture Business Reference Module

Line of Business: Health

Subfunction: Public Health Monitoring

Privacy Act System of Records

Title:

FR Citation:

Number of Respondents: 354

Number of Respondents for Small Entity: 0

Affected Public: Private Sector

Private Sector: Businesses or other for-profits

Percentage of Respondents Reporting Electronically: 99 %

table that charts list of burden
	Approved	Change Due to Adjustment in Agency Estimate	Previously Approved
Annual Number of Responses for this IC	57,630	-9,294	66,924
Annual IC Time Burden (Hours)	1,084,042	-150,153	1,234,195
Annual IC Cost Burden (Dollars)	0	0	0

Documents for IC

table that charts IC Documents
Title	Document	Date Uploaded
No associated records found

Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.